Aminoglycoside Market Analysis By Drug (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin), By Mode of Administration (Feed, Injectables (Parenteral), Intra-mammary, Topical, Oral), By Application (Veterinary, Skin, Respiratory, UTI & Pelvic Disease, Neonatal Sepsis) And Segment Forecasts To 2022

Published: Nov, 2015 | Pages: 84 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)

Global aminoglycoside market is expected to reach USD 1.68 billion by 2022 growing at an estimated CAGR of 3.5% from 2015 to 2022, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to the increasing incidences of animal disease outbreaks leading to high utilization of antibiotics.

However, reduction in prescription rate of aminoglycoside antibiotics due to side effects associated with usage of these drugs that include severe ototoxicity, nephrotoxicity, and neuromuscular blockade are expected to affect the market growth negatively. Furthermore, regulatory disapproval for the usage of certain aminoglycoside in regions is also anticipated to attribute for subordinate growth in this industry.

Further key findings from the report suggest:

Neomycin and tobramycin together contributed for over USD 600 million as revenue in this market owing to higher usage and prescription of these drugs for treatment of different bacterial infections. Neomycin finds higher usage in topical formulations for treatment of different skin infections.
Injectables accounted for the largest share of revenue amongst other routes of administration owing to higher usage for treatment of tuberculosis, MDR-TB, and XDR-TB. Use of second line anti tuberculosis drugs such as kanamycin & capreomycin by global organizations is attributive for generation of maximum revenue in this segment.
Human use for treatment of respiratory disorders accounted for largest share in applications segment owing to rise in global incidence of tuberculosis. Furthermore, other bacterial infections of respiratory tract that can be treated using aminoglycoside class of antibiotics are anticipated to contribute for expected growth in this segment.
Veterinary treatment is expected to boost industrial growth in the coming years owing to higher incidence of animal diseases outbreaks. However, these drugs have restrictive regulations for administration to food-producing animals as it may lead to toxic effects and resistance development on humans after consumption of animal originated food.
Asia Pacific was the largest market, accounting for over 40% of revenue in aminoglycoside industry owing to, the presence of market players in this region coupled with higher rate of tuberculosis incidences herein.
South Africa spearheaded growth in the MEA market. The presence of relatively higher demand and consumption of injectable solutions in this region because of increase in incidence rate of MDR-TB and other drug resistant infections are some regional growth drivers.
Key participants of the aminoglycoside market include Vega Pharma Ltd., Kremoint Pharma Pvt. Ltd, Xian Wison Biological Technology Co., Ltd., Jiangxi Bolai Pharmacy Co., Ltd., Medson Pharmaceuticals, Hangzhou Uniwise International Co., Ltd., Yi Chang Veterinary Medicine Factory, HuvePharma, and Medico Remedies Pvt. Ltd.
Market players are involved in the development of products with newer formulations and lesser side effects in order to treat eradicate bacterial infections that are resistant to other class of antibiotics.

 Table of Content

Chapter 1. Methodology and Scope
              1.1. Research Methodology
              1.2. Research Scope & Assumptions
              1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Industry Outlook
              3.1. Market Segmentation
              3.2. Market Size and Growth Prospects
                 3.2.1. Market Driver Analysis
                 3.2.2. Market Restraint Analysis
              3.3. Aminoglycoside Market Dynamics
              3.4. Key Opportunities Prioritized
              3.5. Industry Analysis - Porter's
              3.6. Aminoglycoside Market PESTEL Analysis
Chapter 4. Aminoglycoside by Product Outlook
              4.1. Neomycin
                 4.1.1. Neomycin Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              4.2. Tobramycin
                 4.2.1. Tobramycin Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              4.3. Gentamicin
                 4.3.1. Gentamicin Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              4.4. Amikacin
                 4.4.1. Amikacin Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              4.5. Paromomycin
                 4.5.1. Paromomycin Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              4.6. Streptomycin
                 4.6.1. Streptomycin Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              4.7. Kanamycin
                 4.7.1. Kanamycin Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              4.8. Other Aminoglycoside
                 4.8.1. Other Aminoglycoside Market Estimates and Forecasts, 2012 - 2022 (USD Million)
Chapter 5. Aminoglycoside Outlook, by Route of Administration
              5.1. Feed
                 5.1.1. Feed Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              5.2. Injectables (Parenteral)
                 5.2.1. Injectables (Parenteral) Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              5.3. Intra-mammary
                 5.3.1. Intra-mammary Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              5.4. Topical
                 5.4.1. Topical Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              5.5. Oral
                 5.5.1. Oral Market Estimates and Forecasts, 2012 - 2022 (USD Million)
Chapter 6. Aminoglycoside Outlook, by Application
              6.1. Veterinary
                 6.1.1. Veterinary Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              6.2. Skin Infection
                 6.2.1. Skin Infection Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              6.3. Respiratory diseases
                 6.3.1. Respiratory diseases Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              6.4. UTI & Pelvic Diseases
                 6.4.1. UTI & Pelvic Diseases Market Estimates and Forecasts, 2012 - 2022 (USD Million)
              6.5. Other diseases
                 6.5.1. Other diseases Market Estimates and Forecasts, 2012 - 2022 (USD Million)
Chapter 7. Aminoglycoside Regional Outlook
              7.1. Aminoglycoside Market Share By Region, 2014 & 2020
              7.2. North America 
                 7.2.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                 7.2.2. U.S.
                      7.2.2.1. Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                      7.2.2.2. Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million)
                      7.2.2.3. Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million)
                 7.2.3. Canada
                      7.2.3.1. Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                      7.2.3.2. Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million)
                      7.2.3.3. Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million)
              7.3. Europe 
                 7.3.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                 7.3.2. Germany
                      7.3.2.1. Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                      7.3.2.2. Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million)
                      7.3.2.3. Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million)
                 7.3.3. UK
                      7.3.3.1. Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                      7.3.3.2. Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million)
                      7.3.3.3. Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million)
              7.4. Asia Pacific
                 7.4.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                 7.4.2. China
                      7.4.2.1. Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                      7.4.2.2. Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million)
                      7.4.2.3. Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million)
                 7.4.3. Japan
                      7.4.3.1. Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                      7.4.3.2. Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million)
                      7.4.3.3. Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million)
              7.5. Latin America
                 7.5.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                 7.5.2. Brazil
                      7.5.2.1. Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                      7.5.2.2. Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million)
                      7.5.2.3. Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million)
              7.6. MEA
                 7.6.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                 7.6.2. South Africa
                      7.6.2.1. Market Estimates and Forecasts, by Product, 2012 - 2022 (USD Million)
                      7.6.2.2. Market Estimates and Forecasts, by Route of Administration, 2012 - 2022 (USD Million)
                      7.6.2.3. Market Estimates and Forecasts, by Application, 2012 - 2022 (USD Million)
Chapter 8. Competitive Landscape
              8.1. Vega Pharma Ltd.
                 8.1.1. Company Overview
                 8.1.2. Financial Performance
                 8.1.3. Product Benchmarking
                 8.1.4. Strategic Development
              8.2. Kremoint Pharma Pvt. Ltd
                 8.2.1. Company Overview
                 8.2.2. Financial Performance
                 8.2.3. Product Benchmarking
                 8.2.4. Strategic Development
              8.3. Xian Wison Biological Technology Co., Ltd.
                 8.3.1. Company Overview
                 8.3.2. Financial Performance
                 8.3.3. Product Benchmarking
                 8.3.4. Strategic Development
              8.4. Jiangxi Bolai Pharmacy Co., Ltd.
                 8.4.1. Company Overview
                 8.4.2. Financial Performance
                 8.4.3. Product Benchmarking
                 8.4.4. Strategic Development
              8.5. Medson Pharmaceuticals
                 8.5.1. Company Overview
                 8.5.2. Financial Performance
                 8.5.3. Product Benchmarking
                 8.5.4. Strategic Development
              8.6. Hangzhou Uniwise International Co., Ltd.
                 8.6.1. Company Overview
                 8.6.2. Financial Performance
                 8.6.3. Product Benchmarking
                 8.6.4. Strategic Development
              8.7. Yi Chang Veterinary Medicine Factory
                 8.7.1. Company Overview
                 8.7.2. Financial Performance
                 8.7.3. Product Benchmarking
                 8.7.4. Strategic Development
              8.8. HuvePharma
                 8.8.1. Company Overview
                 8.8.2. Financial Performance
                 8.8.3. Product Benchmarking
                 8.8.4. Strategic Development
              8.9. Medico Remedies Pvt. Ltd
                 8.9.1. Company Overview
                 8.9.2. Financial Performance
                 8.9.3. Product Benchmarking
                 8.9.4. Strategic Development
              8.10. Alfasan International BV
                 8.10.1. Company Overview
                 8.10.2. Financial Performance
                 8.10.3. Product Benchmarking

List of Tables

1. Aminoglycoside market - Industry Snapshot & Key Buying Criteria, 2012 - 2022
2. Global Aminoglycoside market, by product, 2012 - 2022 (USD Million)
3. Global Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
4. Global Aminoglycoside market, by application, 2012 - 2022 (USD Million)
5. Global Aminoglycoside market, by region, 2012 - 2022 (USD Million)
6. Aminoglycoside- Key market driver analysis
7. Aminoglycoside- Key market restraint analysis
8. North America Aminoglycoside market, by product, 2012 - 2022 (USD Million)
9. North America Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
10. North America Aminoglycoside market, by application, 2012 - 2022 (USD Million)
11. U.S. Aminoglycoside market, by product, 2012 - 2022 (USD Million)
12. U.S. Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
13. U.S. Aminoglycoside market, by application, 2012 - 2022 (USD Million)
14. Canada Aminoglycoside market, by product, 2012 - 2022 (USD Million)
15. Canada Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
16. Canada Aminoglycoside market, by application, 2012 - 2022 (USD Million)
17. Europe Aminoglycoside market, by product, 2012 - 2022 (USD Million)
18. Europe Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
19. Europe Aminoglycoside market, by application, 2012 - 2022 (USD Million)
20. Germany Aminoglycoside market, by product, 2012 - 2022 (USD Million)
21. Germany Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
22. Germany Aminoglycoside market, by application, 2012 - 2022 (USD Million)
23. UK Aminoglycoside market, by product, 2012 - 2022 (USD Million)
24. UK Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
25. UK Aminoglycoside market, by application, 2012 - 2022 (USD Million)
26. Asia Pacific Aminoglycoside market, by product, 2012 - 2022 (USD Million)
27. Asia Pacific Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
28. Asia Pacific Aminoglycoside market, by application, 2012 - 2022 (USD Million)
29. China Aminoglycoside market, by product, 2012 - 2022 (USD Million)
30. China Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
31. China Aminoglycoside market, by application, 2012 - 2022 (USD Million)
32. Japan Aminoglycoside market, by product, 2012 - 2022 (USD Million)
33. Japan Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
34. Japan Aminoglycoside market, by application, 2012 - 2022 (USD Million)
35. Latin America Aminoglycoside market, by product, 2012 - 2022 (USD Million)
36. Latin America Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
37. Latin America Aminoglycoside market, by application, 2012 - 2022 (USD Million)
38. Brazil Aminoglycoside market, by product, 2012 - 2022 (USD Million)
39. Brazil Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
40. Brazil Aminoglycoside market, by application, 2012 - 2022 (USD Million)
41. Latin America Aminoglycoside market, by product, 2012 - 2022 (USD Million)
42. Latin America Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
43. Latin America Aminoglycoside market, by application, 2012 - 2022 (USD Million)
44. Brazil Aminoglycoside market, by product, 2012 - 2022 (USD Million)
45. Brazil Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
46. Brazil Aminoglycoside market, by application, 2012 - 2022 (USD Million)
47. MEA Aminoglycoside market, by product, 2012 - 2022 (USD Million)
48. MEA Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
49. MEA Aminoglycoside market, by application, 2012 - 2022 (USD Million)
50. South Africa Aminoglycoside market, by product, 2012 - 2022 (USD Million)
51. South Africa Aminoglycoside market, by route of administration, 2012 - 2022 (USD Million)
52. South Africa Aminoglycoside market, by application, 2012 - 2022 (USD Million)